Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells

Robert Clarke, Ayesha N. Shajahan, Rebecca B. Riggins, Younsook Cho, Anatasha Crawford, Jianhua Xuan, Yue Wang, Alan Zwart, Ruchi Nehra, Minetta C Liu

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Resistance to endocrine therapies, whether de novo or acquired, remains a major limitation in the ability to cure many tumors that express detectable levels of the estrogen receptor alpha protein (ER). While several resistance phenotypes have been described, endocrine unresponsiveness in the context of therapy-induced tumor growth appears to be the most prevalent. The signaling that regulates endocrine resistant phenotypes is poorly understood but it involves a complex signaling network with a topology that includes redundant and degenerative features. To be relevant to clinical outcomes, the most pertinent features of this network are those that ultimately affect the endocrine-regulated components of the cell fate and cell proliferation machineries. We show that autophagy, as supported by the endocrine regulation of monodansylcadaverine staining, increased LC3 cleavage, and reduced expression of p62/SQSTM1, plays an important role in breast cancer cells responding to endocrine therapy. We further show that the cell fate machinery includes both apoptotic and autophagic functions that are potentially regulated through integrated signaling that flows through key members of the BCL2 gene family and beclin-1 (BECN1). This signaling links cellular functions in mitochondria and endoplasmic reticulum, the latter as a consequence of induction of the unfolded protein response. We have taken a seed-gene approach to begin extracting critical nodes and edges that represent central signaling events in the endocrine regulation of apoptosis and autophagy. Three seed nodes were identified from global gene or protein expression analyses and supported by subsequent functional studies that established their abilities to affect cell fate. The seed nodes of nuclear factor kappa B (NFκB), interferon regulatory factor-1 (IRF1), and X-box binding protein-1 (XBP1) are linked by directional edges that support signal flow through a preliminary network that is grown to include key regulators of their individual function: NEMO/IKKγ, nucleophosmin and ER respectively. Signaling proceeds through BCL2 gene family members and BECN1 ultimately to regulate cell fate.

Original languageEnglish (US)
Pages (from-to)8-20
Number of pages13
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume114
Issue number1-2
DOIs
StatePublished - Mar 2009
Externally publishedYes

Fingerprint

Gene Regulatory Networks
Autophagy
Genes
Cells
Hormones
Apoptosis
Breast Neoplasms
Seeds
Seed
Interferon Regulatory Factor-1
Phenotype
Unfolded Protein Response
Aptitude
Estrogen Receptor alpha
NF-kappa B
Tumors
Cellular Structures
Endoplasmic Reticulum
Neoplasms
Mitochondria

Keywords

  • Antiestrogen
  • Apoptosis
  • Autophagy
  • Breast cancer
  • Cell signaling
  • Endoplasmic reticulum
  • Estrogens
  • Gene networks
  • Unfolded protein response

ASJC Scopus subject areas

  • Molecular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Cell Biology
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells. / Clarke, Robert; Shajahan, Ayesha N.; Riggins, Rebecca B.; Cho, Younsook; Crawford, Anatasha; Xuan, Jianhua; Wang, Yue; Zwart, Alan; Nehra, Ruchi; Liu, Minetta C.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 114, No. 1-2, 03.2009, p. 8-20.

Research output: Contribution to journalArticle

Clarke, Robert ; Shajahan, Ayesha N. ; Riggins, Rebecca B. ; Cho, Younsook ; Crawford, Anatasha ; Xuan, Jianhua ; Wang, Yue ; Zwart, Alan ; Nehra, Ruchi ; Liu, Minetta C. / Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells. In: Journal of Steroid Biochemistry and Molecular Biology. 2009 ; Vol. 114, No. 1-2. pp. 8-20.
@article{f1225102febe4529a7d05bfdee108d24,
title = "Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells",
abstract = "Resistance to endocrine therapies, whether de novo or acquired, remains a major limitation in the ability to cure many tumors that express detectable levels of the estrogen receptor alpha protein (ER). While several resistance phenotypes have been described, endocrine unresponsiveness in the context of therapy-induced tumor growth appears to be the most prevalent. The signaling that regulates endocrine resistant phenotypes is poorly understood but it involves a complex signaling network with a topology that includes redundant and degenerative features. To be relevant to clinical outcomes, the most pertinent features of this network are those that ultimately affect the endocrine-regulated components of the cell fate and cell proliferation machineries. We show that autophagy, as supported by the endocrine regulation of monodansylcadaverine staining, increased LC3 cleavage, and reduced expression of p62/SQSTM1, plays an important role in breast cancer cells responding to endocrine therapy. We further show that the cell fate machinery includes both apoptotic and autophagic functions that are potentially regulated through integrated signaling that flows through key members of the BCL2 gene family and beclin-1 (BECN1). This signaling links cellular functions in mitochondria and endoplasmic reticulum, the latter as a consequence of induction of the unfolded protein response. We have taken a seed-gene approach to begin extracting critical nodes and edges that represent central signaling events in the endocrine regulation of apoptosis and autophagy. Three seed nodes were identified from global gene or protein expression analyses and supported by subsequent functional studies that established their abilities to affect cell fate. The seed nodes of nuclear factor kappa B (NFκB), interferon regulatory factor-1 (IRF1), and X-box binding protein-1 (XBP1) are linked by directional edges that support signal flow through a preliminary network that is grown to include key regulators of their individual function: NEMO/IKKγ, nucleophosmin and ER respectively. Signaling proceeds through BCL2 gene family members and BECN1 ultimately to regulate cell fate.",
keywords = "Antiestrogen, Apoptosis, Autophagy, Breast cancer, Cell signaling, Endoplasmic reticulum, Estrogens, Gene networks, Unfolded protein response",
author = "Robert Clarke and Shajahan, {Ayesha N.} and Riggins, {Rebecca B.} and Younsook Cho and Anatasha Crawford and Jianhua Xuan and Yue Wang and Alan Zwart and Ruchi Nehra and Liu, {Minetta C}",
year = "2009",
month = "3",
doi = "10.1016/j.jsbmb.2008.12.023",
language = "English (US)",
volume = "114",
pages = "8--20",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "1-2",

}

TY - JOUR

T1 - Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells

AU - Clarke, Robert

AU - Shajahan, Ayesha N.

AU - Riggins, Rebecca B.

AU - Cho, Younsook

AU - Crawford, Anatasha

AU - Xuan, Jianhua

AU - Wang, Yue

AU - Zwart, Alan

AU - Nehra, Ruchi

AU - Liu, Minetta C

PY - 2009/3

Y1 - 2009/3

N2 - Resistance to endocrine therapies, whether de novo or acquired, remains a major limitation in the ability to cure many tumors that express detectable levels of the estrogen receptor alpha protein (ER). While several resistance phenotypes have been described, endocrine unresponsiveness in the context of therapy-induced tumor growth appears to be the most prevalent. The signaling that regulates endocrine resistant phenotypes is poorly understood but it involves a complex signaling network with a topology that includes redundant and degenerative features. To be relevant to clinical outcomes, the most pertinent features of this network are those that ultimately affect the endocrine-regulated components of the cell fate and cell proliferation machineries. We show that autophagy, as supported by the endocrine regulation of monodansylcadaverine staining, increased LC3 cleavage, and reduced expression of p62/SQSTM1, plays an important role in breast cancer cells responding to endocrine therapy. We further show that the cell fate machinery includes both apoptotic and autophagic functions that are potentially regulated through integrated signaling that flows through key members of the BCL2 gene family and beclin-1 (BECN1). This signaling links cellular functions in mitochondria and endoplasmic reticulum, the latter as a consequence of induction of the unfolded protein response. We have taken a seed-gene approach to begin extracting critical nodes and edges that represent central signaling events in the endocrine regulation of apoptosis and autophagy. Three seed nodes were identified from global gene or protein expression analyses and supported by subsequent functional studies that established their abilities to affect cell fate. The seed nodes of nuclear factor kappa B (NFκB), interferon regulatory factor-1 (IRF1), and X-box binding protein-1 (XBP1) are linked by directional edges that support signal flow through a preliminary network that is grown to include key regulators of their individual function: NEMO/IKKγ, nucleophosmin and ER respectively. Signaling proceeds through BCL2 gene family members and BECN1 ultimately to regulate cell fate.

AB - Resistance to endocrine therapies, whether de novo or acquired, remains a major limitation in the ability to cure many tumors that express detectable levels of the estrogen receptor alpha protein (ER). While several resistance phenotypes have been described, endocrine unresponsiveness in the context of therapy-induced tumor growth appears to be the most prevalent. The signaling that regulates endocrine resistant phenotypes is poorly understood but it involves a complex signaling network with a topology that includes redundant and degenerative features. To be relevant to clinical outcomes, the most pertinent features of this network are those that ultimately affect the endocrine-regulated components of the cell fate and cell proliferation machineries. We show that autophagy, as supported by the endocrine regulation of monodansylcadaverine staining, increased LC3 cleavage, and reduced expression of p62/SQSTM1, plays an important role in breast cancer cells responding to endocrine therapy. We further show that the cell fate machinery includes both apoptotic and autophagic functions that are potentially regulated through integrated signaling that flows through key members of the BCL2 gene family and beclin-1 (BECN1). This signaling links cellular functions in mitochondria and endoplasmic reticulum, the latter as a consequence of induction of the unfolded protein response. We have taken a seed-gene approach to begin extracting critical nodes and edges that represent central signaling events in the endocrine regulation of apoptosis and autophagy. Three seed nodes were identified from global gene or protein expression analyses and supported by subsequent functional studies that established their abilities to affect cell fate. The seed nodes of nuclear factor kappa B (NFκB), interferon regulatory factor-1 (IRF1), and X-box binding protein-1 (XBP1) are linked by directional edges that support signal flow through a preliminary network that is grown to include key regulators of their individual function: NEMO/IKKγ, nucleophosmin and ER respectively. Signaling proceeds through BCL2 gene family members and BECN1 ultimately to regulate cell fate.

KW - Antiestrogen

KW - Apoptosis

KW - Autophagy

KW - Breast cancer

KW - Cell signaling

KW - Endoplasmic reticulum

KW - Estrogens

KW - Gene networks

KW - Unfolded protein response

UR - http://www.scopus.com/inward/record.url?scp=63149172095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63149172095&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2008.12.023

DO - 10.1016/j.jsbmb.2008.12.023

M3 - Article

C2 - 19444933

AN - SCOPUS:63149172095

VL - 114

SP - 8

EP - 20

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 1-2

ER -